1988
DOI: 10.1021/ja00213a039
|View full text |Cite
|
Sign up to set email alerts
|

Crystal structure, solid-state NMR spectra, and oxygen reactivity of five crystal forms of prednisolone tert-butylacetate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
41
0

Year Published

1996
1996
2011
2011

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 79 publications
(41 citation statements)
references
References 5 publications
0
41
0
Order By: Relevance
“…It is often clear that solid state degradation of pharmaceuticals is often related to molecular mobility [47][48][49] .…”
Section: Phase Transformation During Processingmentioning
confidence: 99%
“…It is often clear that solid state degradation of pharmaceuticals is often related to molecular mobility [47][48][49] .…”
Section: Phase Transformation During Processingmentioning
confidence: 99%
“…Different crystal forms can have relatively large changes in the chemical shift of some resonances. There are many examples of different crystalline forms giving unique NMR spectra [8,[22][23][24][25]. Padden et al have compared solid-state NMR spectroscopy with powder X-ray diffraction (PXRD) in an investigation of neotame polymorphs.…”
Section: Identificationmentioning
confidence: 99%
“…Following the conversion of a mixture of anhydrous forms over time, they found that PXRD could not detect a change in the patterns during the conversion process, whereas up to seven forms were detected in 13 C NMR spectra [25]. Byrn and coworkers have published several papers investigating polymorphism in drug compounds [22,23,26]. In a 13 C study of benoxaprofen, nabilone, and cefazolin, they found that CPMAS NMR spectra of the different crystal forms of the drugs were indeed different [22].…”
Section: Identificationmentioning
confidence: 99%
See 1 more Smart Citation
“…As a result, scientists often rely on the oxidative or other chemical stability of drug candidates in solution to speculate on their behavior in solid state, hoping that the molecules will behave consistently or similarly in these two distinct physical states. However, given the substantial difference in molecular environments between the solid and solution states, the complexity associated with solidstate forms such as polymorphism, hydrates, salts, and the potential of a chemical reaction modulated by topochemistry, 8,9 such a simple extrapolation may prove inadequate and even misleading at times. For a given drug candidate intended to be formulated as a solid dosage form, besides its physicochemical properties such as melting point, solubility, dissolution rate, hygroscopicity, and thermal stability (e.g.…”
Section: Introductionmentioning
confidence: 99%